| Ridley Corporation Limited (RIC) ORDINARY FULLY PAID |
Consumer Staple |
$1,006 |
Completion of Retail Entitlement Offer
|
4 Jun 2025 8:32AM |
$2.780 |
$2.685 |
fallen by
3.42%
|
|
RIC - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Ridley Corporation Limited's retail entitlement offer, raising about $47 million.
- Offer was a 1 for 6.6 pro rata accelerated non-renounceable entitlement offer at $1.80 per new share.
- Total funds raised, including the institutional offer, amount to approximately $89 million.
- Funds will be used for the acquisition of the Narangba Feedmill and other growth projects.
- Retail entitlement offer closed oversubscribed, with strong support from eligible shareholders.
- New shares under the retail entitlement offer are expected to be issued and commence trading on 4 October 2022.
- Announcement thanks shareholders for their participation and support.
- The acquisition and capital raising are expected to position Ridley for further growth.
- There are no material changes to the information previously disclosed in the institutional offer announcement.
- Contact details for further information are provided in the announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coronado Global Resources Inc (CRN) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$411 |
2025 AGM Presentation Materials
|
4 Jun 2025 8:31AM |
$0.105 |
$0.245 |
risen by
133.33%
|
|
| Coronado Global Resources Inc (CRN) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$411 |
2025 AGM Chairman's Address
|
4 Jun 2025 8:30AM |
$0.105 |
$0.245 |
risen by
133.33%
|
|
| Vita Life Sciences Limited (VLS) ORDINARY FULLY PAID |
Health Care |
$132 |
Update - Notification of buy-back - VLS
|
4 Jun 2025 8:30AM |
$1.880 |
$2.420 |
risen by
28.72%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,681 |
Update - Notification of buy-back - NEU
|
4 Jun 2025 8:30AM |
$13.710 |
$13.290 |
fallen by
3.06%
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$29,943 |
Notification of cessation of securities - BXB
|
4 Jun 2025 8:30AM |
$23.460 |
$22.225 |
fallen by
5.26%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$102 |
Cleansing Notice
|
4 Jun 2025 8:30AM |
$0.220 |
$0.345 |
risen by
56.82%
|
|
| Volt Resources Limited (VRC) ORDINARY FULLY PAID |
Materials |
$26 |
Zavalievsky Graphite to Launch June Production Campaign
|
4 Jun 2025 8:29AM |
$0.004 |
$0.005 |
risen by
25%
|
|
| Metals X Limited (MLX) ORDINARY FULLY PAID |
Materials |
$1,440 |
Voluntary Cash Partial Offer to Acquire Greentech Shares
|
4 Jun 2025 8:28AM |
$0.505 |
$1.625 |
risen by
221.78%
|
|
MLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Metals X Limited (MLX) has announced a voluntary cash partial offer to acquire up to 19.9% of the shares in Greentech Metals Limited.
- The offer price is set at $0.50 cash per Greentech share, representing a premium to Greentech’s recent trading prices.
- The offer is voluntary and partial, meaning MLX seeks to acquire only a minority stake (not control) in Greentech.
- The offer is subject to certain conditions, including a minimum acceptance condition and approval from relevant regulatory authorities.
- MLX aims to strengthen its strategic relationship with Greentech, which is focused on exploration and development of battery metals projects.
- The Board of MLX believes this investment aligns with their strategic objectives and enhances exposure to the battery metals sector.
- The offer includes procedural details, such as key dates, how to accept, and the rights of Greentech shareholders.
- A detailed explanation of the rationale and expected benefits for both companies is provided.
- The document outlines potential risks, factors for shareholders to consider, and a summary of the Independent Expert’s Report.
- The Board of Greentech has established an Independent Board Committee to consider the offer and provide recommendations to shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$102 |
Application for quotation of securities - ILA
|
4 Jun 2025 8:27AM |
$0.220 |
$0.345 |
risen by
56.82%
|
|
| NAOS Ex-50 Opportunities Company Limited (NAC) ORDINARY FULLY PAID |
Financials |
$28 |
Update - Notification of buy-back - NAC
|
4 Jun 2025 8:27AM |
$0.445 |
$0.605 |
risen by
35.96%
|
|
| ResMed Inc. (RMD) CDI 10:1 FOREIGN EXEMPT NYSE |
Health Care |
$41,482 |
Statement of Changes in Beneficial Ownership
|
4 Jun 2025 8:27AM |
$37.930 |
$28.600 |
fallen by
24.60%
|
|
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$9 |
Application for quotation of securities - IMC
|
4 Jun 2025 8:27AM |
$0.067 |
$0.029 |
fallen by
56.72%
|
|
| Orica Limited (ORI) ORDINARY FULLY PAID |
Materials |
$10,108 |
Update - Notification of buy-back - ORI
|
4 Jun 2025 8:27AM |
$18.780 |
$21.815 |
risen by
16.16%
|
|
| NAOS Small Cap Opportunities Company Limited (NSC) ORDINARY FULLY PAID |
Financials |
$48 |
Update - Notification of buy-back - NSC
|
4 Jun 2025 8:27AM |
$0.295 |
$0.365 |
risen by
23.73%
|
|
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$616 |
Update - Notification of buy-back - FPR
|
4 Jun 2025 8:27AM |
$2.970 |
$2.855 |
fallen by
3.87%
|
|
| Tyro Payments Limited (TYR) ORDINARY FULLY PAID |
Financials |
$372 |
Tyro Appoints New Director
|
4 Jun 2025 8:26AM |
$0.885 |
$0.700 |
fallen by
20.90%
|
|
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$67 |
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
|
4 Jun 2025 8:26AM |
$0.026 |
$0.019 |
fallen by
26.92%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Radiopharm Theranostics Limited (RAD) announced the dosing of the first patient in its Phase 1 therapeutic clinical trial of 177Lu-RAD202.
- RAD202 is a novel radiotherapeutic being developed for the treatment of specific cancer types.
- The trial is a first-in-human study designed to evaluate the safety, tolerability, and preliminary efficacy of 177Lu-RAD202.
- The first patient was dosed at the Princess Alexandra Hospital in Brisbane, Australia.
- This milestone represents a significant step in RAD's clinical development pipeline and aligns with the company's growth strategy.
- RAD202 targets the CD3 receptor, a marker present in various cancer types, using a radiolabeled antibody approach.
- The trial's initial phase will focus on safety and dose escalation to determine the maximum tolerated dose.
- Future trial phases may assess efficacy in a wider patient population based on initial safety data.
- Radiopharm Theranostics Limited specializes in radiopharmaceutical products for diagnostic and therapeutic purposes in oncology.
- The announcement underscores RAD's commitment to advancing innovative cancer therapies using targeted radionuclide technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ResMed Inc. (RMD) CDI 10:1 FOREIGN EXEMPT NYSE |
Health Care |
$41,482 |
Statement of Changes in Beneficial Ownership
|
4 Jun 2025 8:26AM |
$37.930 |
$28.600 |
fallen by
24.60%
|
|
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$6,846 |
Final Director's Interest Notice - RYAN
|
4 Jun 2025 8:26AM |
$17.540 |
$24.245 |
risen by
38.23%
|
|
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$1,703 |
Notification of cessation of securities - ORA
|
4 Jun 2025 8:26AM |
$1.885 |
$1.390 |
fallen by
26.26%
|
|
| Minerals 260 Limited (MI6) ORDINARY FULLY PAID |
Materials |
$1,805 |
Bullabulling Gold Project Drilling Results
|
4 Jun 2025 8:26AM |
$0.145 |
$0.798 |
risen by
450%
|
|
MI6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Minerals 260 Limited (MI6) released its first 2024 drilling results from the Bullabulling Gold Project.
- Significant gold mineralisation was intersected at Gibraltar, Phoenix, and Elvire prospects.
- Reverse circulation (RC) drilling confirmed thickness and grade of gold intercepts.
- Results indicate strong potential for resource growth and further exploration.
- Initial drilling focused on expanding known mineralised zones and testing new targets.
- Ongoing drilling will continue to refine and extend current findings.
- Bullabulling Gold Project is shaping up as a potential significant gold resource in Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Shriro Holdings Limited (SHM) ORDINARY FULLY PAID |
Consumer Discretionary |
$47 |
Change of Director's Interest Notice
|
4 Jun 2025 8:26AM |
$0.680 |
$0.730 |
risen by
7.35%
|
|
| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$146 |
Update - Notification of buy-back - VVA
|
4 Jun 2025 8:25AM |
$1.310 |
$1.485 |
risen by
13.36%
|
|
| OFX Group Limited (OFX) ORDINARY FULLY PAID |
Financials |
$131 |
AGM and Nomination of Directors
|
4 Jun 2025 8:25AM |
$0.690 |
$0.565 |
fallen by
18.12%
|
|